31 research outputs found
Measurement of low-energy antiproton detection efficiency in BESS below 1 GeV
An accelerator experiment was performed using a low-energy antiproton beam to
measure antiproton detection efficiency of BESS, a balloon-borne spectrometer
with a superconducting solenoid. Measured efficiencies showed good agreement
with calculated ones derived from the BESS Monte Carlo simulation based on
GEANT/GHEISHA. With detailed verification of the BESS simulation, the relative
systematic error of detection efficiency derived from the BESS simulation has
been determined to be 5%, compared with the previous estimation of
15% which was the dominant uncertainty for measurements of cosmic-ray
antiproton flux.Comment: 13 pages, 7 figure
Measurements of atmospheric muon spectra at mountain altitude
We report new measurements of the atmospheric muons at mountain altitude. The
measurement was carried out with the BESS detector at the top of Mt. Norikura,
Japan. The altitude is 2,770 m above sea level. Comparing our results and
predictions given by some interaction models, a further appropriate model has
been investigated. These studies would improve accuracy of atmospheric neutrino
calculations.Comment: Mean momentum in Table 1 was correcte
<b>A new type of spider toxin, Nephilatoxin, in the venom of the Joro spider, <i>Nephila </i></b><b><i>clavata </i></b>
A Novel Inhibitor of I-KappaB Kinase Beta Ameliorates Experimental Arthritis through Downregulation of Proinflammatory Cytokines in Arthritic Joints
Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with <sup>211</sup>At Using Implanted Mouse Tumor
Recent introduction of alpha-emitting radionuclides in targeted radionuclide therapy has stimulated the development of new radiopharmaceuticals. Preclinical evaluation using an animal experiment with an implanted tumor model is frequently used to examine the efficiency of the treatment method and to predict the treatment response before clinical trials. Here, we propose a mathematical model for evaluation of the tumor response in an implanted tumor model and apply it to the data obtained from the previous experiment of 211At treatment in a thyroid cancer mouse model. The proposed model is based on the set of differential equations, describing the kinetics of radiopharmaceuticals, the tumor growth, and the treatment response. First, the tumor growth rate was estimated from the control data without injection of 211At. The kinetic behavior of the injected radionuclide was used to estimate the radiation dose profile to the target tumor, which can suppress the tumor growth in a dose-dependent manner. An additional two factors, including the time delay for the reduction of tumor volume and the impaired recovery of tumor regrowth after the treatment, were needed to simulate the temporal changes of tumor size after treatment. Finally, the parameters obtained from the simulated tumor growth curve were able to predict the tumor response in other experimental settings. The model can provide valuable information for planning the administration dose of radiopharmaceuticals in clinical trials, especially to determine the starting dose at which efficacy can be expected with a sufficient safety margin
Acute Traumatic Patellar Tendon Rupture at the Tibial Tuberosity Attachment without Avulsion Fracture
Patellar tendon rupture in children is especially rare. The fact that the area of traumatic rupture has wide variations makes surgical treatment difficult. We present an 11-year-old boy with acute traumatic patellar tendon rupture at the tibial tuberosity attachment without avulsion fracture. Primary end-to-end repair and reinforcement using 1.5 mm stainless steel wires as a surgical strategy were undertaken. Early range of motion began with a functional knee brace and the reinforced stainless wire was removed 3 months after surgery. Knee function at the final follow-up was satisfactory. We suggest that this strategy may provide a useful option for surgical treatment